|
Link Directly to
Content
Drugs
and Chemicals of Concern > Oxycodone
-
OxyContin Theft and Loss Incidents
- Data from the DEA Drug and Loss System (Prepared October 2003)
-
OxyContin Diversion and Abuse
Download PDF (October 2003)
-
Congressional
Testimony regarding Oxycodone by Terrance W. Woodworth, Deputy
Director, DEA, Office of Diversion Control
-
Congressional
Testimony regarding Oxycodone by Asa Hutchinson, Administrator, Drug
Enforcement Administration
-
Drug
Summary
-
DEA-Industry Communicator (OxyContin
Special) 2001
-
Summary of
Medical Examiner Reports on Oxycodone-Related Deaths (May 16,
2002)
- Drug Enforcement
Adminstration, 21 Health Groups Call for Balanced Policy on Prescription
Pain Medication Like OxyContin PDF (October 23, 2001)
- Promoting Pain Relief
and Preventing Abuse of Pain Medications: A Critical Balancing Act PDF
(October 23, 2001)
-
Action Plan to Prevent the Diversion and
Abuse of OxyContin®
(June 22, 2001)
-
Frequently
Asked Questions
Download Adobe
Acrobat Reader to view and print PDF files
Hot
Items
Program
Description | Offices &
Directories | Drug Registration | ARCOS
| Chemical Program |
Publications
| Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
|
Controlled
Substance Schedules | Drugs and
Chemicals of Concern | Federal Register
Notices |
Electronic Commerce Initiatives | Quotas
| Import Export | Meetings
and Events | Career Opportunities |
Links
|
FAQ's | What's New |
Site Map | Search | Home
| On-Line Forms & Applications | NFLIS
Contact Us
|